More C-suite changes at Dyne

In the latest C-suite changes at Dyne Therapeutics Inc. (NASDAQ:DYN), the biotech added two new members to its team. Vikram Ranade joined as CBO following a stint as SVP of corporate development at Tessera Therapeutics Inc. Ranjan Batra, formerly VP of research and translation at Lexeo Therapeutics Inc. (NASDAQ:LXEO), is Dyne’s new CSO. The company’s current CSO, Oxana Beskrovnaya, will become chief innovation officer.

Since John Cox took the reins from Joshua Brumm as Dyne’s CEO last year, the musculoskeletal company has also replaced its CFO and CMO, and its COO has departed. Some former team members have reconvened at Crescent Biopharma Inc...